May 16, 2012

Asthma is having a growing effect on the country's health, according to a new study.

March 26, 2012

The Food and Drug Administration has approved a drug made by Teva for treating allergies, the company said Monday.

March 20, 2012

Novartis has launched a new treatment for chronic obstructive pulmonary disease, the drug maker said Monday.

March 12, 2012

Melville, N.Y.-based Ascent Consumer Products late last month introduced a new delivery form to the nasal saline category — a dry salt inhaler branded InHalo — as a new solution to help break up mucous and promote nasal and bronchial drainage at the ECRM Cough & Cold and Allergy EPPS conference held here.

March 9, 2012

The Food and Drug Administration has approved a version of a drug made by Teva that includes a dose counter, the drug maker said.

March 5, 2012

A drug under development by Teva Pharmaceutical Industries appears safe and effective in treating allergies, according to results of a late-stage clinical trial released Monday.

February 24, 2012

In preparation for spring, the American College of Allergy, Asthma and Immunology on Friday noted that avoiding certain fruits and vegetables, installing the proper air filters, closing the windows, filling any allergy prescriptions and consulting with an allergist can all prevent the delay of allergy symptom relief for more than 35 million Americans who suffer from seasonal allergies.

February 21, 2012

Sen. Charles Schumer on Tuesday announced that the Food and Drug Administration has agreed to conduct a full review of the safety and legality of the new caffeine inhaler AeroShot, distributed by Breathable Foods, which hit stores in New York and Boston this past month.

February 17, 2012

As of the beginning of February, the cough-cold season had yet to materialize and illness levels were only just beginning to climb. If that’s the case, then an expected illness peak in late February/early March would make the 2011-2012 cough, cold and flu season one of the later-peaking seasons in recent years.


February 17, 2012

Asthma has been becoming more relevant in the nonprescription aisles of late.

February 17, 2012

One of the main plotlines of the big story called the drug industry over the past several years has been the patent cliff, the steady loss of patent protection on blockbuster primary care drugs and subsequent generic competition that has forced many drug companies to find new revenue streams.

February 14, 2012

Generic drug maker Mylan plans to challenge a court decision that requires it to pay almost $20 million to a drug company whose product it tried to market as a generic.

January 25, 2012

Medical device maker PMD Healthcare has launched what it calls the first personal spirometer to monitor lung function, the company said.

November 9, 2011

Generic drug maker Mylan has bought rights to a drug delivery platform made by Pfizer that will allow it to make generic versions of two GlaxoSmithKline respiratory drugs, Mylan said Wednesday.

October 10, 2011

The Food and Drug Administration has approved a new product for chronic obstructive pulmonary disease made by Boehringer Ingelheim Pharmaceuticals, the drug maker said.

October 4, 2011

Growing numbers of Americans with asthma and chronic obstructive pulmonary disease are driving innovation among drug makers, according to a new report by Frost & Sullivan.

September 27, 2011

There seems to be a significant presence of asthma among children with diabetes, and those with both chronic illnesses have a difficult time controlling their blood-sugar levels, according to new research.

September 22, 2011

Epinephrine inhalers will not be made or sold after Dec. 31, and patients using them should get new prescriptions to replace them, the Food and Drug Administration said Thursday.

August 8, 2011

An investigational treatment made by Roche for asthma increased lung function in patients who could not adequately control their disease with inhaled corticosteroids, according to results of a mid-stage clinical trial.

August 4, 2011

The National Advertising Division of the Council of Better Business Bureaus on Thursday recommended that Nu Century Herbs discontinue certain disease-state claims promoting the company’s Resprin dietary supplement.

May 31, 2011

Researchers at Children's Hospital Boston have discovered the reason why influenza may induce asthma attacks among children.

May 26, 2011

A health education television network has added nine condition-specific networks.

May 26, 2011

A recent Quest Diagnostics "Health Trends Report" released Wednesday raised the possibility that men have a higher risk for allergies than women or that men, as a function of their gender, require different reporting standards when evaluated for allergies with increasingly used blood tests.

May 25, 2011

HealthPrize Technologies and RealAge will launch a study next month that will test HealthPrize’s medication adherence technologies on patients taking asthma medications, the two companies said Wednesday.